{"disease":{"id":"chronic-hepatitis-d-infection","name":"chronic hepatitis d infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT06248580","title":"Find HDV and Determine Its Status in Turkey","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Yaşar Bayındır, MD","has_results":false},{"nct_id":"NCT05181956","title":"Testing and Epidemiology of Delta Hepatitis","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Asian Pacific Liver Center at Coalition of Inclusive Medicine","has_results":false},{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT05792878","title":"Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT07200908","title":"A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":172,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07499544","title":"A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT03546621","title":"A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Hepatera Ltd.","has_results":true},{"nct_id":"NCT05861674","title":"A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT05760300","title":"A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02637999","title":"Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Hepatera Ltd.","has_results":true},{"nct_id":"NCT05827146","title":"Study of Hepalatide in Chronic Hepatitis D(CHD) Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Shanghai HEP Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04638439","title":"The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"PharmaEssentia","has_results":false},{"nct_id":"NCT03723824","title":"Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT05674448","title":"A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infection","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT06780579","title":"Expanded Access for Bulevirtide","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Gilead Sciences","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}